Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 03, 2020 16:15 ET | Source: Teligent, Inc.

Teligent Announces Conversion Rate Adjustment for its 7.0% Cash / 8.0% PIK Series B Senior Unsecured Convertible Notes Due 2023 and its 4.75% Convertible Senior Notes Due 2023

BUENA, N.J., June 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today conversion...
May 26, 2020 16:30 ET | Source: Teligent, Inc.

Teligent Announces One-for-Ten Reverse Stock Split

BUENA, N.J., May 26, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that as of...
May 22, 2020 07:30 ET | Source: Teligent, Inc.

Teligent, Inc. Announces First Quarter 2020 Results

BUENA, N.J., May 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter...
May 19, 2020 17:00 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for First Quarter 2020 Results on Friday May 22nd, 2020

BUENA, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on...
April 08, 2020 07:30 ET | Source: Teligent, Inc.

TELIGENT, INC. ANNOUNCES FOURTH QUARTER AND YEAR END 2019 RESULTS & AMENDMENTS TO EXISTING SECURED CREDIT FACILITIES

BUENA, N.J., April 08, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth...
April 03, 2020 16:05 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Fourth Quarter and 2019 Full Year Financial Results on Wednesday April 8, 2020

BUENA, N.J., April 03, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00 a.m. ET...
February 05, 2020 08:21 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Transition in Leadership

BUENA, N.J., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, today announced a transition...
December 23, 2019 17:12 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Request for Further Data on Complex Drug

BUENA, N.J., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its development partner has received a...
November 13, 2019 12:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at Jefferies Global Healthcare Conference in London on Wednesday November 20, 2019

BUENA, N.J., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies Global Healthcare...
November 04, 2019 16:15 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Third Quarter 2019 Results

BUENA, N.J., Nov. 04, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter...